iBio, Inc.
IBIO
$1.04
-$0.03-2.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.79% | -- | -- | -9.40% | 48.71% |
| Total Depreciation and Amortization | -1.37% | -- | -- | 1.08% | -1.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.43% | -- | -- | 16.41% | -91.90% |
| Change in Net Operating Assets | -6,712.50% | -- | -- | 38.25% | 82.21% |
| Cash from Operations | -22.75% | -- | -- | -4.15% | 23.47% |
| Capital Expenditure | -3,100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46,754.35% | -- | -- | -100.14% | -- |
| Cash from Investing | -47,862.22% | -- | -- | -100.28% | 595.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 12.57% | -- | -- | -2.41% | 86.60% |
| Issuance of Common Stock | -86.56% | -- | -- | 350.00% | -99.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 681.94% | -- | -- | -- | -- |
| Cash from Financing | 470.97% | -- | -- | 6.17% | -101.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 441.47% | -- | -- | -27.15% | -139.58% |